The field of neurology is showing promising advancements with stem cell therapy treatments.

space-header

Multiple Sclerosis

Multiple Sclerosis is a debilitating neurological disease that is thought to be caused by destruction of the myelin sheath (fatty protective insulation) around axons of the brain and spinal cord. Loss of myelin impacts the ability of these tissues to conduct signals. The inflammatory process can lead to scarring, resulting in a broad range of symptoms. This myelin damage appears to be related primarily to an autoimmune dysfunction, but there also appears to be environmental and genetic factors involved. There is no known cure for the physical and cognitive defects associated with chronic Multiple Sclerosis. Many investigators are looking at using the regenerative properties of stem cell therapy to mitigate the impact of Multiple Sclerosis on the central nervous system.

brainMultiple Sclerosis and Cell Surgical Network has developed a specific SVF deployment protocol that attempts to utilize the immuno-regulatory and anti-inflammatory properties of SVF (rich in mesenchymal stem cells and growth factors). Special measures are taken to optimize transport of the SVF across the blood-brain barrier to improve central nervous system uptake. This is all done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Multiple Sclerosis Call to Action

We care about our Multiple Sclerosis patients at the Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out our Confidential Candidate Application, we will answer the questions and concerns you may have about Cell Surgical Network protocols for Multiple Sclerosis.

Peripheral Neuropathy (PN)

nervesPeripheral Neuropathy (PN) is a degenerative disorder of the nerves (usually of the hands and feet) and has many causes including traumatic injuries, infections (neuritis), metabolic problems and exposure to toxins. One of the most common causes is diabetes, and many cases are due to autoimmune disorders, but frequently, the cause of neuropathy cannot be identified.  Peripheral Neuropathy (PN) often causes symptoms of numbness and pain described as burning or tingling. Physicians use a number of medications to reduce the painful symptoms of peripheral neuropathy. Some cases progress and are resistant to medical therapy, making it difficult to manage symptoms. There is hope that mesenchymal stem cells will mitigate some of the degenerative effects of neuropathy.

Peripheral Neuropathy and Cell Surgical Network has developed a specific SVF deployment protocol that attempts to utilize the potential immune-modulatory and regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is deployed systemically as well as injected locally into soft tissue. This is all done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately four hours.

Peripheral Neuropathy Call to Action We care about our Peripheral Neuropathy patients at the Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out our Confidential Candidate Application, we will answer the questions and concerns you may have about Cell Surgical Network protocols for Peripheral Neuropathy.

ALS

ALS also known as Lou Gehrig’s disease is a debilitating neurological disease that results from the destruction of upper and lower motor neurons in the brain and spinal cord. ALS is associated with rapidly progressive weakness, muscle wasting, spasticity, and difficulty breathing, swallowing and speaking. There is no known cause for ALS and genetics are implicated in only 5% of cases. There is no known cure for the physical defects associated with ALS. Many investigators are looking at using the regenerative properties of cell therapy to mitigate the impact of ALS on the nervous system.

ALS and Cell Surgical Network

The Cell Surgical Network has developed a specific SVF deployment protocol that attempts to utilize the immuno-regulatory, regenerative, and anti-inflammatory properties of SVF (rich in mesenchymal stem cells and growth factors). Special measures are taken to optimize transport of the SVF across the blood-brain barrier to improve central nervous system uptake. This is all done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

ALS Call to Action

We care about our ALS patients at the Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out a Confidential Candidate Application.  We will answer the questions and concerns you may have about our Stem Cell Treatment Centers and Cell Surgical Network protocols for ALS. Our Cell Surgical Network has Treatment Centers in several states. Locate the closest Treatment Center using Our Physician Network Map.

Parkinson's Disease

Parkinson’s Disease (PD) is a degenerative disorder of the central nervous system that affects close to one million Americans. PD is a chronic and progressive disorder that is thought to be caused by destruction of the dopamine (an important neurotransmitter) generating cells in the midbrain. The cause of PD is unknown and there is no cure so treatment is focused on medication and management of symptoms. Current research directions include investigations into new animal models of the disease and of the potential usefulness of gene therapy, stem cell transplants and neuro-protective agents. There is hope that mesenchymal stem cells will mitigate the degenerative effects of advancing Parkinson’s.

Parkinson’s Disease and Cell Surgical Network has developed a specific SVF deployment protocol that attempts to utilize the potential regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). Special measures are taken to optimize transport of the SVF across the blood-brain barrier to improve central nervous system uptake. This is all done on an outpatient basis at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Parkinsons Disease Call to Action

We care about our Parkinson’s patients at the Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out our Confidential Candidate Application, we will answer the questions and concerns you may have about Cell Surgical Network protocols for Parkinson’s Disease. Our Cell Surgical Network has Treatment Centers in several states. Locate the closest Treatment Center using Our Physician Network Map.

Muscular Dystrophy

Muscular Dystrophy (MD) is a disease characterized by progressive skeletal muscle weakness, defects in muscle proteins (dystrophin concentration is greatly reduced), and the death of muscle cells and tissue. Diagnosis is based on muscle biopsy, laboratory evaluation (increased levels of creatine phosphokinase) and EMG findings. There are nine major types of MD and most types of MD are multi-system disorders with manifestations in body systems including the heart, gastrointestinal system, nervous system, endocrine glands, eyes and brain. MD has a strong genetic link. Treatment options are limited. There has been a keen interest in using stem cells to regenerate muscle tissue and there has been success in using human stem cells for MD in mice. There is hope that adipose derived stem cells may be effective in regenerating muscle damaged by MD.

Muscular Dystrophy and Cell Surgical Network has developed a specific SVF deployment protocol that attempts to utilize the potential regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is systemically deployed and is expected to hone in to damaged areas preferentially. This is all done on an outpatient basis at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Muscular Dystrophy Call to Action

We care about our Muscular Dystrophy patients at the Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out our Confidential Candidate Application, we will answer the questions and concerns you may have about Cell Surgical Network protocols for Muscular Dystrophy. Our Cell Surgical Network has Treatment Centers in several states,. Locate the closest Treatment Center using Our Physician Network Map.

Stroke

Stroke, also known as cerebro-vascular accident, is caused by a disturbance in blood supply to the brain. Stroke affects millions of Americans every year. The result is ischemic brain injury which means that part of the brain has suffered from lack of oxygen and this has resulted in vital tissue destruction. Symptoms vary depending on the anatomic location of the event, extent and duration of the tissue loss. After acute management, long term healing must occur, which requires management of swelling and neovascularization of damaged tissue. Researchers, particularly in Europe, have been actively studying the use of mesenchymal stem cells to help promote healing after ischemic brain injury.

Stroke Recovery and Cell Surgical Network has developed a specific SVF deployment protocol that attempts to utilize the anti-inflammatory and potential regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is systemically deployed and is expected to focus on damaged areas of the central nervous system. Special measures are taken to optimize transport of the SVF across the blood-brain barrier to improve central nervous system uptake. This is all done on an outpatient basis at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Stroke Recovery Call to Action

We care about our Stroke Recovery patients at the Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out our Confidential Candidate Application, we will answer the questions and concerns you may have about and Cell Surgical Network protocols for Stroke Recovery. Our Cell Surgical Network has Treatment Centers in several states. Locate the closest Treatment Center using Our Physician Network Map.

Follow Us

Visit Us On FacebookVisit Us On YoutubeVisit Us On LinkedinVisit Us On TwitterVisit Us On GooglePlus

Join us for our next webinar!

Select a date that works for you!
CLICK FOR DETAILS >>

Stem Cells and the FDA

Stem cell treatment is not approved by the FDA for any specific disease.
CLICK FOR DETAILS >>

Blog Posts